REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sarospharma Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sarospharma Cia.Ltda Profile Updated: April 09, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sarospharma Cia.Ltda is a company in Ecuador, with a head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on January 07, 2015. The total number of employees is currently 8 (2023). The company’s latest financial report indicates a net sales revenue drop of 18.52% in 2023. Over the same period, its total assets decreased by 1.25%. In 2023, Sarospharma Cia.Ltda’s net profit margin decreased by 2.52%.

Headquarters
Inaquito 0 Cheriove N47-75
Quito; Pichincha;

Contact Details: Purchase the Sarospharma Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Sarospharma Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Sarospharma Cia.Ltda report to view the information.
Registered Capital:
Purchase the Sarospharma Cia.Ltda report to view the information.
Incorporation Date:
January 07, 2015
Key Executives
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Sarospharma Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-18.52%▼
Total operating revenue
-18.52%▼
Operating profit (EBIT)
-43.09%▼
Net Profit (Loss) for the Period
-51.63%▼
Total assets
-1.25%▼
Total equity
2.91%▲
Operating Profit Margin (ROS)
-1.87%▼
Net Profit Margin
-2.52%▼
Return on Equity (ROE)
-14.22%▼
Debt to Equity Ratio
-0.17%▼
Quick Ratio
-17.86%▼
Cash Ratio
-9.69%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo